Literature DB >> 16611102

Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT.

Anna Cirulli1, Maria Paola Loria, Porzia Dambra, Francesca Di Serio, Maria T Ventura, Luigi Amati, Emilio Jirillo, Carlo Sabbà.   

Abstract

Hereditary Hemorrhagic Telangiectasia (HHT) is a rare genetic disease characterized by mutations occurring in the endoglin and ALK-1, two receptors of transforming growth factor-beta1. From a pathogenic point of view, a possible involvement of the immune system in HHT has been suggested since a mononuclear cell infiltrate was found around the area of telangiectases. Up until now, no information has been available about the role played by leukocytes in HHT and the mechanisms elicited by secretion of their mediators. However, the fact that a deficit of adaptive immunity in HHT has been reported in a companion paper in this issue will represent a great contribution to the understanding of HHT pathogenesis. The purpose of this study was to evaluate whether patients with HHT manifest also alterations in the innate immune response. Therefore, the phenotype of T, B and natural killer lymphocytes, serum immunoglobulin levels, phagocytosis and oxidative burst activity exerted by polymorphonuclear cells (PMN) and monocytes (MO) were analyzed in 22 patients. Twenty individuals demonstrated single or multiple deficits of PMN and MO functions, while the immunophenotype of lymphocytes and serum concentrations of immunoglobulins were normal. To the best of our knowledge, this is the first demonstration of a reduction in PMN and MO functions in HHT, thus suggesting a higher susceptibility to infectious complications in these patients. The relationship between innate immune deficits and T helper 1 and monocyte-derived cytokine dysfunction in HHT, as previously reported, is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611102     DOI: 10.2174/138161206776361336

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  14 in total

1.  Infection prevention in patients with hereditary hemorrhagic telangiectasia.

Authors:  Juan Rodríguez-García; Roberto Zarrabeitia-Puente; Rafael Fernández-Santos; José Antonio García-Erce
Journal:  Haematologica       Date:  2018-10       Impact factor: 9.941

2.  Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations.

Authors:  Hanny Al-Samkari; Athena Kritharis; David J Kuter
Journal:  Haematologica       Date:  2018-10       Impact factor: 9.941

3.  Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia.

Authors:  Sun K Kim; Roberto Romero; Zeynep A Savasan; Yi Xu; Zhong Dong; Deug-Chan Lee; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Reprod Immunol       Date:  2012-12-24       Impact factor: 3.886

Review 4.  Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling.

Authors:  Jason B Wheeler; John S Ikonomidis; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  Brain abscess caused by Enterococcus faecalis following a dental procedure in a patient with hereditary hemorrhagic telangiectasia.

Authors:  Eleni Mylona; Chariklia Vadala; Vasilios Papastamopoulos; Athanasios Skoutelis
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

6.  Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor-β Signaling.

Authors:  Jason B Wheeler; John S Ikonomidis; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Hereditary haemorrhagic telangiectasia: a clinical and scientific review.

Authors:  Fatima S Govani; Claire L Shovlin
Journal:  Eur J Hum Genet       Date:  2009-04-01       Impact factor: 4.246

8.  Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review.

Authors:  Vincent Q Sier; Joost R van der Vorst; Paul H A Quax; Margreet R de Vries; Elham Zonoobi; Alexander L Vahrmeijer; Ilona A Dekkers; Lioe-Fee de Geus-Oei; Anke M Smits; Weibo Cai; Cornelis F M Sier; Marie José T H Goumans; Lukas J A C Hawinkels
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

9.  Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response.

Authors:  Luisa Ojeda-Fernández; Lucía Recio-Poveda; Mikel Aristorena; Pedro Lastres; Francisco J Blanco; Francisco Sanz-Rodríguez; Eunate Gallardo-Vara; Mateo de las Casas-Engel; Ángel Corbí; Helen M Arthur; Carmelo Bernabeu; Luisa M Botella
Journal:  PLoS Genet       Date:  2016-03-24       Impact factor: 5.917

10.  Comorbidity among HHT patients and their controls in a 20 years follow-up period.

Authors:  Katrine Saldern Aagaard; Anette Drøhse Kjeldsen; Pernille Mathiesen Tørring; Anders Green
Journal:  Orphanet J Rare Dis       Date:  2018-12-14       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.